• About
  • Masthead
  • License Content
  • Advertise
  • Press Releases
  • Newsroom
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

Sign in
SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
Sign in
SUBSCRIBE
2 Minute Medicine
Sign in
Subscribe
2 Minute MedicineFree on Google PlayGet
✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Gastroenterology

Intrahepatic cholestasis of pregnancy linked to poor outcomes

byDenise PongandLeah Hawkins Bressler, MD, MPH
September 1, 2014
in Gastroenterology, Obstetrics
Reading Time: 2 mins read
Intrahepatic cholestasis of pregnancy linked to poor outcomes
Share on FacebookShare on TwitterShare on LinkedIn

1. Higher bile acid levels were associated with preterm delivery, meconium-stained amniotic fluid and perinatal death.

2. Maternal bile acid levels were correlated with umbilical cord bile acid levels.

Evidence Rating Level: 2 (Good)

Study Rundown: Intrahepatic cholestasis of pregnancy (ICP) is the most common liver disease among pregnant women. The condition is characterized by pruritus and elevated bile acid levels; transaminase levels may or may not be elevated. Because the itchiness and lab abnormalities typically resolve after delivery, ICP is a relatively harmless condition to pregnant women and symptoms can typically be managed with ursodeoxycholic acid. However, ICP has more significant adverse effects on fetal outcomes. Prior work identifies associations with ICP and adverse fetal outcomes, including preterm delivery and intrauterine fetal demise. In the present study, authors found that severe ICP, defined as total bile acid levels ≥100µmol/L, was associated with lower birthweight, preterm delivery, meconium-stained fluid, and perinatal death. Additionally, authors found that severe ICP was correlated with umbilical cord bile acid levels. These findings suggest that maternal bile acid levels may be useful in predicting risk for adverse fetal outcomes for infants being born to mothers suffering from ICP. These risk predictions may be helpful in guiding testing and management to improve fetal outcomes.

Limitations of the study include retrospective design and small sample size, such that the incidence of adverse outcomes may be misrepresented. Future work should include larger, prospective cohort studies to confirm the findings observed here. If future studies yield similar results, more precise bile acid level cut-offs may be helpful in triaging pregnancies at high-risk for fetal demise or other adverse outcomes.

Click to read the study in AJOG

RELATED REPORTS

Maternal use of benzodiazepines and non-benzodiazepine hypnotics is not associated with increased risk of psychiatric

Maternal smoking is associated with increased risk of sudden unexpected infant death

Relevant Reading: Intrahepatic cholestasis of pregnancy: molecular pathogenesis, diagnosis and management

In-Depth [retrospective cohort study]: This study evaluated the relationship between bile acid levels and adverse pregnancy outcomes in 215 women diagnosed with ICP by elevated total bile acids. ICP was classified as mild, total bile acid 10-39µmol/L (n=108); moderate, bile acid 40-99µmol/L (n=86); or severe, bile acid ≥100µmol/L (n=21). Outcomes of interest included mode of delivery, meconium staining of amniotic fluid, preterm delivery, postpartum hemorrhage, small for gestational age, NICU admission and death.

Severe ICP was associated with lower birthweight (p=0.009), preterm birth (p=0.03), meconium-stained fluid (p=0.003), postpartum hemorrhage (p=0.019) and perinatal death (p=0.009). Furthermore, every 10µmol/L was associated with increased likelihood for spontaneous preterm delivery (OR 1.15, CI 1.03-1.28) and meconium-stained fluid (OR 1.15, CI 1.06-1.25). The highest measured maternal bile acid level was positively correlated with umbilical cord bile acid levels (p=0.006).

More from this author: Severe acne linked to endometriosis, Postpartum pelvic floor muscles may have limited value, Vitamin D not effective in reducing recurrent bacterial vaginosis, Cervical length may predict preterm delivery, Recurrent pregnancy loss associated with increased cardiovascular morbidity

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. PLEASE SEE A HEALTHCARE PROVIDER IN YOUR AREA IF YOU SEEK MEDICAL ADVICE OF ANY SORT.

Tags: cholestasispregnancy
Previous Post

Artificial turf may increase risk of anterior cruciate ligament injury

Next Post

Amelanotic melanoma linked with advanced stage at diagnosis

RelatedReports

Prenatal antidepressant exposure may increase risk of poor motor development
Chronic Disease

Maternal use of benzodiazepines and non-benzodiazepine hypnotics is not associated with increased risk of psychiatric

May 6, 2026
Strict tobacco licensing laws linked to reduced adolescent smoking initiation
Obstetrics

Maternal smoking is associated with increased risk of sudden unexpected infant death

April 9, 2026
Risk of autism in offspring linked to maternal pregestational diabetes and severe obesity
Weekly Rewinds

2 Minute Medicine Rewind March 23, 2026

March 23, 2026
Non-alcoholic fatty liver disease and risk of incident acute myocardial infarction and stroke: findings from matched cohort study of 18 million European adults
Neurology

Functional recovery after maternal ischemic stroke may be commonly favourable

January 26, 2026
Next Post
Teledermatology may be reliable in triaging inpatient dermatology consultations

Amelanotic melanoma linked with advanced stage at diagnosis

Combo angiotensin-neprilysin inhibitor superior to enalapril in heart failure [PARADIGM-HF trial]

Combo angiotensin-neprilysin inhibitor superior to enalapril in heart failure [PARADIGM-HF trial]

Ivabradine ineffective in stable coronary artery disease [SIGNIFY trial]

Ivabradine ineffective in stable coronary artery disease [SIGNIFY trial]

✦ EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... Try EvidencePulse™ Get the signal. Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

3-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

NPI Lookup · Free

Look up any US clinician

Search by name or NPI number, live from the CMS NPI Registry.

  • OIG exclusion check
  • Licenses and specialties
  • No account needed
Open NPI Lookup →

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • An electronic health record tool for exercise prescription may reduce fall rate among older adults
  • Optogenetic therapy may partially restore vision in retinitis pigmentosa
  • An artificial intelligence system for human papillomavirus-positive dual stain cervical cancer screening reads p16-Ki67 slides
License Content
Terms of Use | Disclaimer
Cookie Policy

Get the app

Read 2 Minute Medicine on iPhone, iPad and Android.

Download on the App StoreGet it on Google Play
QR code for www.2minutemedicine.com/app
On a computer? Scan this with your phone’s camera.
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

3-day free trial · cancel anytime

Start 3-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free

Start 3-day free trial

Then $49.90/year.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
  • ✓NPI watchlist + bulk NPI verification

Already a member? Sign in

  • Get the app
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
    • Rewinds
    • The Scan
  • EvidencePulse™
  • HypeCheck™
  • AI News
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Tools
    • NPI Registry Lookup
    • RVU Search
  • Partners
    • License Content
    • Advertise with Us
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.